The Journal of Clinical Oncology (JCO) is a medical journal published 3 times a month (36 issues a year) by the American Society of Clinical Oncology (ASCO), with a 2010 impact factor of 18.970. JCO now accounts for nearly one in 10 of all oncology journal citations. This journal s focus is work that relates to the care of patients with cancer, e.g., clinical oncology. This journal publishes in varying formats. Original research reports are both a communication tool and reports for original research. Review articles can describe work that builds on previous original research, summarize the current state clinical oncology, or can be a point of critical analysis. Opinion is voiced in editorial formats, which include commentary and discuss controversies. There is also a format for perspectives from a person of public notoriety. Special articles are another form of communication besides original research reports, which promulgate guidelines, summaries of consensus, and other scholarly communications. Fundamental research is covered in the "Biology of Neoplasia" section.
As cancer treatment and survivorship care relies more on understanding the genetic make-up of an individual's tumor, a new study from the University of Michigan Health Rogel Cancer Center finds that many breast cancer survivors ...
Jul 16, 2024
0
0
Early detection of lung cancer through low-dose computed tomography screening is one of the most promising strategies to reduce lung cancer mortality among high-risk individuals.
Aug 5, 2024
0
7
A new artificial intelligence (AI) test to determine the risk of bowel cancers coming back could help patients avoid chemotherapy, according to new research led by the University of Leeds.
Jul 31, 2024
0
0
A new study shows that by combining different chemotherapy drugs, testicular cancer remains highly treatable and often curable, even after first-line treatment fails. .
Jul 19, 2024
0
0
The Stockholm3 blood test, developed by researchers at Karolinska Institutet, is equally effective at detecting prostate cancer in different ethnic groups, a new paper published in the Journal of Clinical Oncology reports. ...
Jul 22, 2024
0
0
A new generation of artificial intelligence (AI) tools designed to allow rapid, low-cost detection of clinically actionable genomic alterations directly from tumor biopsy slides has been developed by a team led by engineers ...
Jul 31, 2024
0
0
Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding metastasis-directed radiation therapy to standard-of-care chemotherapy improved progression-free survival (PFS) in patients ...
Aug 5, 2024
0
1
Axicabtagene ciloleucel, commonly known as axi-cel, is an innovative immunotherapy that uses modified T cells to target and destroy cancer cells. Approved for patients who have not responded to at least two prior lines of ...
Aug 5, 2024
0
0
Two Medicaid policies can interact to increase oncology clinical trial enrollment among Black and Hispanic patients, according to a new study by investigators at Weill Cornell Medicine, the University of Pennsylvania, and ...
Jul 25, 2024
0
0
Scientists from St. Jude Children's Research Hospital, Seattle Children's and the Children's Oncology Group (COG) have identified novel genetic variations that influence relapse risk in children with standard risk B-cell ...
Aug 12, 2024
0
0
